Asa Abeliovich serves as Executive at Prevail Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Asa Abeliovich has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 22, 2021 involved transacting 2,385,756 shares valued at $0.
Asa Abeliovich currently holds 2,354,256 shares of Prevail Therapeutics Inc. (PRVL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Asa Abeliovich has been a net neutral trader of PRVL stock. They have purchased $0 and sold $0 worth of shares.
Asa Abeliovich's most recent insider trade was on Jan 22, 2021, when they sold 2,385,756 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.18 |
| Discretionary |
| Dec 30, 2020 | PRVL | $1.2M | Option Exercise | 120,537 | $10.26 | Discretionary |
| Dec 30, 2020 | PRVL | $2.0M | Payment | 89,037 | $23.02 | Discretionary |